Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Rheumatoid Arthritis: HELP
Lisa Marshall
Based on 7 articles published since 2009
(Why 7 articles?)
||||
Expertise Level
The expertise of Lisa Marshall ranks in the
  • Top 4%
  • ... of 82,356 published authors worldwide on Rheumatoid Arthritis
  • ... from 2009 through 2019
  • ... based on contributions to 7 articles on the topic.
Graphical view (beta)
Work Locations
Details
Most likely:    Pfizer      
2018
  • Division of Allergy, Immunology and Rheumatology, Department of Medical Education and Research, Taichung Veterans General Hospital, Taichung, Taiwan. · Institute of Biomedical Science and Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung, Taiwan. · Division of Rheumatology and Clinical Immunology, The University of Hong Kong, Pokfulam, Hong Kong. · Department of Rheumatology, Cairo University, Cairo, Egypt. · National Taiwan University, Taipei, Taiwan. · University Medical Center, Ljubljana, Slovenia. · Regional Medical Affairs, Pfizer, Brussels, Belgium. · Global Medical Affairs, Pfizer, Collegeville, Pennsylvania, USA. · Medical and Regulatory Affairs, Pfizer, Inc., Makati City, Philippines. · Pubmed 29205904
  • Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. · Hietzing Hospital, Vienna, Austria. · inVentiv Health, Princeton, NJ, USA. · Pfizer, Collegeville, PA, USA. · Pubmed 29338762
2017
  • Division of Rheumatology and Clinical Immunology, The University of Hong Kong, Pok Fu Lam, Hong Kong. · Hospital for Special Surgery and Weill Cornell Medicine, New York, NY, USA. · Belgrade University School of Medicine, Belgrade, Serbia. · Envision Pharma Group, Market Access Solutions, London, UK. · Medical Affairs, Pfizer, Collegeville, PA, USA. · Leeds Institute of Molecular Medicine, University of Leeds, Leeds, UK. · Pubmed 28852832
  • Division of Immunology/Rheumatology, Stanford University School of Medicine, 306 Ramona Road, Portola Valley, CA, 94028, USA. · Rheumatology Unit, Instituto de Investigación Sanitaria del Hospital Universitario La Paz (IdiPAZ), Madrid, Spain. · Rheumatology Section, Dubai Hospital, Dubai, United Arab Emirates. · Hospital de Especialidades Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, México City, Mexico. · Department of Internal Medicine, Kyushu University Beppu Hospital, Beppu, Japan. · Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. · Market Access Solutions, Envision Pharma Group, London, UK. · Pfizer Ltd, Surrey, UK. · Medical Affairs, Pfizer, Collegeville, PA, USA. · Pubmed 28612180
2016
  • Pfizer, Collegeville, Pennsylvania, USA. · Pfizer, Andover, Massachusetts, USA. · Pfizer UK, Surrey, UK. · Pubmed 27034452
2015
  • Metroplex Clinical Research Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA. · Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Specialty Care, Pfizer Inc, Collegeville, Pennsylvania, USA. · Pubmed 25143522
2014
  • Department of Medicine, Division of Rheumatology, University of Texas Southwestern Medical Center, Dallas, TX, Pfizer Inc., Collegeville, PA, USA and Pfizer Europe, Rome, Italy · Department of Medicine, Division of Rheumatology, University of Texas Southwestern Medical Center, Dallas, TX, Pfizer Inc., Collegeville, PA, USA and Pfizer Europe, Rome, Italy. · Pubmed 24907147
Probable:    University of Texas Southwestern   Contact    
2014
  • Department of Medicine, Division of Rheumatology, University of Texas Southwestern Medical Center, Dallas, TX, Pfizer Inc., Collegeville, PA, USA and Pfizer Europe, Rome, Italy · Department of Medicine, Division of Rheumatology, University of Texas Southwestern Medical Center, Dallas, TX, Pfizer Inc., Collegeville, PA, USA and Pfizer Europe, Rome, Italy. · Pubmed 24907147
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Lisa Marshall in 2009-2019 about Rheumatoid Arthritis:

  • Dosing down and then discontinuing biologic therapy in rheumatoid arthritis: a review of the literature. 2018
  • Predictors of remission with etanercept-methotrexate induction therapy and loss of remission with etanercept maintenance, reduction, or withdrawal in moderately active rheumatoid arthritis: results of the PRESERVE trial. 2018
  • Down-titration of biologics for the treatment of rheumatoid arthritis: a systematic literature review. 2017
  • Immunogenicity of Biologics in Chronic Inflammatory Diseases: A Systematic Review. 2017
  • Comparing the immunogenicity of the etanercept biosimilar SB4 with the innovator etanercept: another consideration. 2016
  • How much does Disease Activity Score in 28 joints ESR and CRP calculations underestimate disease activity compared with the Simplified Disease Activity Index? 2015
  • Short-term efficacy of etanercept plus methotrexate vs combinations of disease-modifying anti-rheumatic drugs with methotrexate in established rheumatoid arthritis. 2014
Show List of Full Article Records
Google Searches

Learn more about Lisa Marshall using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Pfizer
University of Texas Southwestern
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Pfizer
2018
  • Division of Allergy, Immunology and Rheumatology, Department of Medical Education and Research, Taichung Veterans General Hospital, Taichung, Taiwan. · Institute of Biomedical Science and Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung, Taiwan. · Division of Rheumatology and Clinical Immunology, The University of Hong Kong, Pokfulam, Hong Kong. · Department of Rheumatology, Cairo University, Cairo, Egypt. · National Taiwan University, Taipei, Taiwan. · University Medical Center, Ljubljana, Slovenia. · Regional Medical Affairs, Pfizer, Brussels, Belgium. · Global Medical Affairs, Pfizer, Collegeville, Pennsylvania, USA. · Medical and Regulatory Affairs, Pfizer, Inc., Makati City, Philippines. · Pubmed 29205904
  • Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. · Hietzing Hospital, Vienna, Austria. · inVentiv Health, Princeton, NJ, USA. · Pfizer, Collegeville, PA, USA. · Pubmed 29338762
2017
  • Division of Rheumatology and Clinical Immunology, The University of Hong Kong, Pok Fu Lam, Hong Kong. · Hospital for Special Surgery and Weill Cornell Medicine, New York, NY, USA. · Belgrade University School of Medicine, Belgrade, Serbia. · Envision Pharma Group, Market Access Solutions, London, UK. · Medical Affairs, Pfizer, Collegeville, PA, USA. · Leeds Institute of Molecular Medicine, University of Leeds, Leeds, UK. · Pubmed 28852832
  • Division of Immunology/Rheumatology, Stanford University School of Medicine, 306 Ramona Road, Portola Valley, CA, 94028, USA. · Rheumatology Unit, Instituto de Investigación Sanitaria del Hospital Universitario La Paz (IdiPAZ), Madrid, Spain. · Rheumatology Section, Dubai Hospital, Dubai, United Arab Emirates. · Hospital de Especialidades Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, México City, Mexico. · Department of Internal Medicine, Kyushu University Beppu Hospital, Beppu, Japan. · Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. · Market Access Solutions, Envision Pharma Group, London, UK. · Pfizer Ltd, Surrey, UK. · Medical Affairs, Pfizer, Collegeville, PA, USA. · Pubmed 28612180
2016
  • Pfizer, Collegeville, Pennsylvania, USA. · Pfizer, Andover, Massachusetts, USA. · Pfizer UK, Surrey, UK. · Pubmed 27034452
2015
  • Metroplex Clinical Research Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA. · Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Specialty Care, Pfizer Inc, Collegeville, Pennsylvania, USA. · Pubmed 25143522
2014
  • Department of Medicine, Division of Rheumatology, University of Texas Southwestern Medical Center, Dallas, TX, Pfizer Inc., Collegeville, PA, USA and Pfizer Europe, Rome, Italy · Department of Medicine, Division of Rheumatology, University of Texas Southwestern Medical Center, Dallas, TX, Pfizer Inc., Collegeville, PA, USA and Pfizer Europe, Rome, Italy. · Pubmed 24907147
University of Texas Southwestern
2014
  • Department of Medicine, Division of Rheumatology, University of Texas Southwestern Medical Center, Dallas, TX, Pfizer Inc., Collegeville, PA, USA and Pfizer Europe, Rome, Italy · Department of Medicine, Division of Rheumatology, University of Texas Southwestern Medical Center, Dallas, TX, Pfizer Inc., Collegeville, PA, USA and Pfizer Europe, Rome, Italy. · Pubmed 24907147
Yearly article counts 02211100000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.